ZymoGenetics, Inc.'s Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding

Published: Oct 26, 2009

Bookmark and Share

Xconomy.com -- One of the key people who transformed ZymoGenetics from a basic research institute into a more balanced biotech company with both R and D, has set up shop in a rival startup just a few blocks away on Seattleā€™s Eastlake Avenue. If he plays his cards right, this little company will surpass his former employer, with what he hopes will be an even better treatment to control bleeding.

Back to news